Status:

ACTIVE_NOT_RECRUITING

Ayaangwaamiziwin Initiative: Carefulness and Preparedness

Lead Sponsor:

Unity Health Toronto

Conditions:

Point-of-Care Testing

HIV

Eligibility:

All Genders

16+ years

Phase:

NA

Brief Summary

The goal of this clinical trial is to implement a test, treat, and connect intervention approach using HIV and syphilis rapid point-of-care (POC) testing in 3 Canadian Prairie provinces (Alberta, Mani...

Detailed Description

The goal of this clinical trial is to implement a test, treat, and connect intervention approach using HIV and syphilis rapid point-of-care (POC) testing in 3 Canadian Prairie provinces (Alberta, Mani...

Eligibility Criteria

Inclusion

  • Test participants:
  • Individuals \> 16 years old accessing STBBI testing at specific locations
  • Able to provide informed consent.
  • Due to the number of sites across SK, AB, and MB, the diversity of the sites and local teams and the incremental addition of sites as the project progresses, the total number of participants to be recruited over the duration of the study (3 years), will be 10,000 individuals and there will be no requirement on local sample size, for the participating sites. (Please refer to Risks and Benefits). A competitive recruitment process will be in place and monitored closely throughout the study.

Exclusion

  • \< 16 years
  • Unable to provide signed informed consent (e.g., intoxicated)
  • Non-Healthcare Professional Operators For the purposes of this study, the untrained non-HCP operators are defined as the personnel, including community health navigators who in the opinion of the Principal Investigator are able to perform the study procedures outlined in this protocol and who are employed by the site. These operators will only be using the investigational device in this study - Multiplo® Complete Syphilis point-of-care test.
  • Inclusion criteria:
  • Individuals \> 18 years old
  • Are able to read/understand English or French
  • Are able to provide informed consent
  • Are paid employees of the study site(s)
  • Are able to perform the study procedures outlined in the protocol
  • Exclusion criteria:
  • Individuals \< 18 years old
  • Have used or watched someone use the Multiplo® Complete Syphilis Test prior to this study
  • Are regulated healthcare professionals including nurses, nurse practitioners, physicians, dentists, pharmacists, and laboratory technologists
  • Healthcare Professional Operators For the purposes of this study, the healthcare professionals are defined as the paid personnel who in the opinion of the Principal Investigator are able to perform the study procedures outlined in this protocol and who are employed by the site.
  • Inclusion criteria:
  • Regulated healthcare professional
  • Are able to read/understand English or French
  • Are able to provide informed consent
  • Are paid employees of the study site(s)
  • Are able to perform the study procedures outlined in the protocol
  • Exclusion criteria:

Key Trial Info

Start Date :

February 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2028

Estimated Enrollment :

10000 Patients enrolled

Trial Details

Trial ID

NCT06893159

Start Date

February 1 2025

End Date

March 1 2028

Last Update

March 25 2025

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

Radius Community Health & Healing

Edmonton, Alberta, Canada, T5H 2J2

2

StreetWorks

Edmonton, Alberta, Canada, T5H 2J2

3

Northreach Society

Grande Prairie, Alberta, Canada, T8V 5B6

4

Siloam Mission

Winnipeg, Manitoba, Canada, R3B 1M3